Skip to Content

barr 882 (Hydroxyurea 500 mg)

Pill with imprint barr 882 is Pink & Purple, Capsule-shape and has been identified as Hydroxyurea 500 mg. It is supplied by Teva Pharmaceuticals USA.

Hydroxyurea is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors; cervical cancer; glioblastoma multiforme (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for barr 882

Hydroxyurea 500 mg barr 882
Hydroxyurea 500 mg barr 882 Front
Hydroxyurea 500 mg barr 882 Back
Hydroxyurea 500 mg barr 882


barr 882
500 mg
Pink & Purple
22.00 mm
Prescription only
Drug Class:
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
citric acid anhydrous
benzyl alcohol
ferrosoferric oxide
carboxymethylcellulose sodium
D&C Red No. 28
D&C Yellow No. 10
aluminum oxide
sodium phosphate dibasic
edetate calcium disodium
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
lactose monohydrate
magnesium stearate
propylparaben sodium
propylene glycol
ferric oxide red
sodium lauryl sulfate
sodium propionate
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0321 AvKare, Inc.
54868-4773 Physicians Total Care Inc. (repackager)
54569-5715 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.